23 research outputs found
Les pneumopathies nosocomiales en réanimation de CHU Hassan II de FÚs
L'objectif principal de notre étude était d'identifier les bactéries incriminées dans la pneumopathie nosocomiale (PN) au service de réanimation A1 du CHU Hassan II de FÚs, en vue d'en améliorer la prise en charge et de diminuer la morbi-mortalité associée. Il s'agit d'une étude rétrospective et descriptive, menée du 1er janvier 2012 au 31 décembre 2013. Seules les infections pulmonaires survenant au-delà de 48 heures de l'admission du patient au service de réanimation ont été incluses. L'incidence de la PN était de 11,2%. Les Bacilles à Gram négatif (BGN) étaient retrouvés dans 48,5% des cas, le Staphylocoque Aureus dans 21,21% des cas et le Klebsiella Pneumoniae était dans 10,7% des cas. Le taux de mortalité était de 48,33%. L'ùge, la gravité de la pathologie sous jacente et le retard de l'instauration d'une antibiothérapie adaptée étaient considérées comme facteurs de mauvais pronostic. L'étude de la résistance aux antibiotiques, montre une multirésistance surtout pour les BGN, dont il faut tenir compte en mettant en place une stratégie de prévention active.Pan African Medical Journal 2015; 2
Un syndrome malin des neuroleptiques compliquĂ© dâhĂ©morragie mĂ©ningĂ©e et rĂ©vĂ©lant une vascularite cĂ©rĂ©brale
Le syndrome malin des neuroleptiques est une complication du traitement par les neuroleptiques. Son incidence est estimĂ©e Ă 0,02% dans la population gĂ©nĂ©rale. Le traitement reste symptomatique et repose essentiellement sur l'arrĂȘt immĂ©diat du traitement antĂ©rieur. Nous rapportons l'observation clinique d'une patiente de 26 ans, schizophrĂ©nique sous Chlorpromazine, se prĂ©sentant aux urgences pour la prise en charge d'un syndrome malin des neuroleptiques compliquĂ© d'une hĂ©morragie mĂ©ningĂ©e et rĂ©vĂ©lant une vascularite cĂ©rĂ©brale
Constraints to Economic Development and Growth in the Middle East and North Africa
When comparing the speed and extent of economic development in different geographic
regions of the world over the past 20 years, the under-average performance of Arab countries
in general and Arab Mediterranean countries in particular is striking. This is despite
an overall favorable geo-strategic situation at the crossroads of three continents, with excellent
connections to sea and waterways and in direct proximity to the European Union,
one of the worldâs economic hubs. It is also despite the minor importance of negative factors
such as a high-burden diseases or high levels of ethnic fractionalization.
In this paper, I focus on identifying the most important constraints on Arab Mediterranean
economic development. I use state-of-the-art econometric tools to quantify constraints that
have been identified through economic theory and studies of the political economy characteristics
of the region. The empirical results offer support for the central hypothesis that
limited technological capacities and political economy structures are the primary constraints
on economic development. With a view to international structural adjustment efforts,
my findings imply that the limited success of the Euro-Mediterranean policy to
stimulate the economic development of the Arab Mediterranean countries might be because
structural adjustment efforts do not tackleâor at least do not sufficiently tackleâ
these constraints.Vergleicht man Geschwindigkeit und Umfang der wirtschaftlichen Entwicklung der verschiedenen
Weltregionen in den vergangenen zwanzig Jahren, so fÀllt insbesondere das
unterdurchschnittliche Abschneiden der arabischen LĂ€nder im Allgemeinen und der arabischen
MittlemeerlÀnder im Besonderen ins Auge, und dies trotz einer insgesamt vorteilhaften
geographischen Lage im Schnittpunkt dreier Kontinente mit exzellenten Anschlussmöglichkeiten
an See- und Wasserwege, trotz der direkten Nachbarschaft zum
Weltwirtschaftsdrehkreuz EuropÀische Union und trotz der relativ geringen Bedeutung
wichtiger entwicklungshemmender Faktoren, beispielsweise ethnische Zersplitterung oder
massive Ausbreitung von Krankheiten wie AIDS oder Malaria.
In diesem Aufsatz wird versucht, von den unterschiedlichen Hemmfaktoren wirtschaftlicher
Entwicklung, die in der wirtschaftstheoretischen Literatur und/oder in MENARegionalstudien
diskutiert werden, diejenigen herauszuarbeiten, die wirtschaftliche Entwicklung
am stÀrksten behindern oder möglicherweise stÀrker als andere. Dabei benutze
ich modernste ökonometrische Verfahren, um den Einfluss der verschiedenen erklÀrenden
Variablen zu quantifizieren. Die Ergebnisse stĂŒtzen die Eingangshypothese, dass insbesondere
mangelnde technologische KapazitÀten und FÀhigkeiten sowie regionalspezifische
politökonomische Strukturen die wirtschaftliche Entwicklung in den arabischen MittelmeerlÀndern
behindern
Natural resource exploitation in Western Sahara: new research directions
The authors wish to thank the Leverhulme Trust (through their Early Career scheme) and the Spanish Ministry of Economy, Industry and Competitivity, (CSO2017-86986-P, AEI/FEDER, UE) for funding this research. We would also like to thank Patricia Lalonde for her translations and editorial work, as well as all participants of the 'Analysis of the Management and Exploitation of Natural Resources in Situations of Conflict: The Case of Western Sahara' project (funded by the aforementioned ministry), for their constructive comments on earlier iterations of this paper.This review article provides an overview of research to date with an explicit focus on natural resource exploitation in Western Sahara. It integrates findings from various perspectives and disciplines, and synthesises the research done with a view to revealing gaps and, therefore, potential new research directions. As the issue of natural resource exploitation in Western Sahara has been conceptualised in very different ways and from the perspectives of a variety of disciplines, the authors have opted for a semi-systematic review of the work done encompassing academic, non-academic, and activist backgrounds.Leverhulme TrustSpanish Ministry of Economy, Industry and Competitivity (AEI/FEDER, UE)
CSO2017-86986-
Global wealth disparities drive adherence to COVID-safe pathways in head and neck cancer surgery
Peer reviewe
Elective cancer surgery in COVID-19-free surgical pathways during the SARS-CoV-2 pandemic: An international, multicenter, comparative cohort study
PURPOSE As cancer surgery restarts after the first COVID-19 wave, health care providers urgently require data to determine where elective surgery is best performed. This study aimed to determine whether COVID-19âfree surgical pathways were associated with lower postoperative pulmonary complication rates compared with hospitals with no defined pathway. PATIENTS AND METHODS This international, multicenter cohort study included patients who underwent elective surgery for 10 solid cancer types without preoperative suspicion of SARS-CoV-2. Participating hospitals included patients from local emergence of SARS-CoV-2 until April 19, 2020. At the time of surgery, hospitals were defined as having a COVID-19âfree surgical pathway (complete segregation of the operating theater, critical care, and inpatient ward areas) or no defined pathway (incomplete or no segregation, areas shared with patients with COVID-19). The primary outcome was 30-day postoperative pulmonary complications (pneumonia, acute respiratory distress syndrome, unexpected ventilation). RESULTS Of 9,171 patients from 447 hospitals in 55 countries, 2,481 were operated on in COVID-19âfree surgical pathways. Patients who underwent surgery within COVID-19âfree surgical pathways were younger with fewer comorbidities than those in hospitals with no defined pathway but with similar proportions of major surgery. After adjustment, pulmonary complication rates were lower with COVID-19âfree surgical pathways (2.2% v 4.9%; adjusted odds ratio [aOR], 0.62; 95% CI, 0.44 to 0.86). This was consistent in sensitivity analyses for low-risk patients (American Society of Anesthesiologists grade 1/2), propensity scoreâmatched models, and patients with negative SARS-CoV-2 preoperative tests. The postoperative SARS-CoV-2 infection rate was also lower in COVID-19âfree surgical pathways (2.1% v 3.6%; aOR, 0.53; 95% CI, 0.36 to 0.76). CONCLUSION Within available resources, dedicated COVID-19âfree surgical pathways should be established to provide safe elective cancer surgery during current and before future SARS-CoV-2 outbreaks
Elective Cancer Surgery in COVID-19-Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study.
PURPOSE: As cancer surgery restarts after the first COVID-19 wave, health care providers urgently require data to determine where elective surgery is best performed. This study aimed to determine whether COVID-19-free surgical pathways were associated with lower postoperative pulmonary complication rates compared with hospitals with no defined pathway. PATIENTS AND METHODS: This international, multicenter cohort study included patients who underwent elective surgery for 10 solid cancer types without preoperative suspicion of SARS-CoV-2. Participating hospitals included patients from local emergence of SARS-CoV-2 until April 19, 2020. At the time of surgery, hospitals were defined as having a COVID-19-free surgical pathway (complete segregation of the operating theater, critical care, and inpatient ward areas) or no defined pathway (incomplete or no segregation, areas shared with patients with COVID-19). The primary outcome was 30-day postoperative pulmonary complications (pneumonia, acute respiratory distress syndrome, unexpected ventilation). RESULTS: Of 9,171 patients from 447 hospitals in 55 countries, 2,481 were operated on in COVID-19-free surgical pathways. Patients who underwent surgery within COVID-19-free surgical pathways were younger with fewer comorbidities than those in hospitals with no defined pathway but with similar proportions of major surgery. After adjustment, pulmonary complication rates were lower with COVID-19-free surgical pathways (2.2% v 4.9%; adjusted odds ratio [aOR], 0.62; 95% CI, 0.44 to 0.86). This was consistent in sensitivity analyses for low-risk patients (American Society of Anesthesiologists grade 1/2), propensity score-matched models, and patients with negative SARS-CoV-2 preoperative tests. The postoperative SARS-CoV-2 infection rate was also lower in COVID-19-free surgical pathways (2.1% v 3.6%; aOR, 0.53; 95% CI, 0.36 to 0.76). CONCLUSION: Within available resources, dedicated COVID-19-free surgical pathways should be established to provide safe elective cancer surgery during current and before future SARS-CoV-2 outbreaks
Variation in postoperative outcomes of patients with intracranial tumors: insights from a prospective international cohort study during the COVID-19 pandemic
Background:
This study assessed the international variation in surgical neuro-oncology practice and 30-day outcomes of patients who had surgery for an intracranial tumor during the COVID-19 pandemic.
Methods:
We prospectively included adults aged â„18 years who underwent surgery for a malignant or benign intracranial tumor across 55 international hospitals from 26 countries. Each participating hospital recorded cases for 3 consecutive months from the start of the pandemic. We categorized patientsâ location by World Bank income groups (high [HIC], upper-middle [UMIC], and low- and lower-middle [LLMIC]). Main outcomes were a change from routine management, SARS-CoV-2 infection, and 30-day mortality. We used a Bayesian multilevel logistic regression stratified by hospitals and adjusted for key confounders to estimate the association between income groups and mortality.
Results:
Among 1016 patients, the number of patients in each income group was 765 (75.3%) in HIC, 142 (14.0%) in UMIC, and 109 (10.7%) in LLMIC. The management of 200 (19.8%) patients changed from usual care, most commonly delayed surgery. Within 30 days after surgery, 14 (1.4%) patients had a COVID-19 diagnosis and 39 (3.8%) patients died. In the multivariable model, LLMIC was associated with increased mortality (odds ratio 2.83, 95% credible interval 1.37â5.74) compared to HIC.
Conclusions:
The first wave of the pandemic had a significant impact on surgical decision-making. While the incidence of SARS-CoV-2 infection within 30 days after surgery was low, there was a disparity in mortality between countries and this warrants further examination to identify any modifiable factors